Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,821,229
+$221,213 QoQ
Shares Held
41,796
-40.6% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 211 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. ANAB ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in ANAB
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,821,229 | 41,796 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,600,016 | 46,881 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,966,344 | 61,187 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,043,298 | 66,731 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,780,728 | 80,213 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,413,225 | 76,021 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $880,026 | 66,467 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,208,952 | 65,939 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,576,051 | 62,891 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,329,757 | 59,048 | Shares | Defined | 2024-05-15 | |
| 2022-12-31 | $470,520 | 15,183 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $403,925 | 15,834 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $338,825 | 16,691 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $412,933 | 16,691 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||